JUNIPER GROUP INC
10QSB, 1998-08-14
INSURANCE AGENTS, BROKERS & SERVICE
Previous: OMEGA HEALTH SYSTEMS INC, 10-Q, 1998-08-14
Next: NATIONAL SECURITY GROUP INC, 10-Q, 1998-08-14





                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   Form 10-QSB





QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 
OF 1934

                             For the quarterly period ended June 30, 1998
                             ---------------------------------------------

                             Commission file number    0-19170


                              JUNIPER GROUP, INC.
 -------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)


      Nevada                                               11-2866771
- -------------------------------------------------------------------------------
 (State or other jurisdiction of               (IRS Employer Identification No.)
 incorporation or organization)

           111 Great Neck Road, Suite 604, Great Neck, New York 11021
- --------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (516) 829-4670
- --------------------------------------------------------------------------------
                           (Issuer's telephone number)



- --------------------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                          if changed since last report)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days.   Yes  X      No
                                                                ---        ---




     The number of shares  outstanding of each of the issuer's classes of common
equity, as of the latest practicable date, August 11, 1998, was 1,840,471 shares
of common stock - $.001 par value.



Transitional Small Business Disclosure Format:  Yes       No  X
                                                   ---       ---


                                       1
<PAGE>
        
PART I - FINANCIAL INFORMATION

ITEM 1:   Financial Statements



                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                           CONSOLIDATED BALANCE SHEETS

                                                        June          December 
       Assets                                        30, 1998        31, 1997 
                                                    -----------    -----------
Current Assets
  Cash ...........................................   $    21,601    $    30,187
 Accounts receivable - trade ....................        450,506        363,480
  Due from affiliates ............................        10,261         15,570 
  Prepaid expenses and other current assets ......       143,362        141,098
  Due from officer ...............................        95,895           -   
                                                     -----------    -----------
      Total current assets .......................       721,625        550,335
  Film licenses ..................................     2,954,562      2,954,562
  Property and equipment net of accumulated
    depreciation of $69,271 and $127,382
    respectively .................................        66,732         98,911
  Other assets ...................................         1,788          2,049
                                                     -----------    -----------
                                                     $ 3,744,707    $ 3,605,857
                                                     ===========    ===========

       LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
  Accounts payable and accrued expenses ..........   $   817,835    $   835,427
  Notes payable - current ........................       742,305        342,571
  Due to producers - current .....................        39,586         62,086
  Due to officer .................................          -            68,662
  Due to shareholders ............................         7,000          7,000
                                                     -----------    -----------
       Total current liabilities .................     1,606,726     1,315,746
Due to producers - long term .....................        62,496         93,814
                                                     -----------    -----------
       Total liabilities .........................     1,669,222      1,409,560
                                                     -----------    -----------
Shareholders' Equity
  12% Non-voting convertible redeemable
   preferred stock: $.10 par value, 875,000
   shares authorized, 235,900 shares issued
   and outstanding at June 30, 1998, and
   December 31, 1997: aggregate liquidation
   preference, $471,800 at June 30, 1998
   and December 31, 1997 .........................        23,590         23,590
  Common Stock - $.001 par value, 6,000,000
   shares authorized, 1,300,698 and 759,915
   issued and outstanding at June 30, 1998
   and December 31, 1997 respectively  ...........         1,301            760
  Capital contributions in excess of par:
   Attributed to preferred stock .................       210,303        210,303
   Attributed to common stock ....................     8,568,688      7,971,979
  Retained earnings (deficit) ....................    (6,728,397)    (6,010,335)
                                                     -----------    -----------
   Total shareholders' equity ....................     2,075,485      2,196,297
                                                     -----------    -----------
                                                     $ 3,744,707    $ 3,605,857 
                                                     ===========    ===========

                 See Notes to Consolidated Financial Statements

                                      2
<PAGE>



                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                        CONSOLIDATED STATEMENTS OF INCOME





                                                      Three Months Ended
                                                   June 30,           June 30,
                                                     1998              1997
                                                ------------       ------------
Revenues:
     Healthcare ..............................  $    284,144       $    302,492
     Entertainment ...........................        10,000               -
                                                ------------       ------------
                                                     294,144            302,492
                                                ------------       ------------

Operating Costs:
     Healthcare ..............................        34,683            124,115
     Entertainment ...........................         2,293               -   
Selling, general and administrative expenses .       474,391            443,874
Settlement Expense                                   267,236               - 
                                                ------------       ------------
                                                     778,603            567,989
                                                ------------       ------------

Net income (loss) ............................  $   (484,459)          (265,497)
                                                ============       ============
Weighted average number of shares outstanding      1,052,235            433,548 
                                                ============       ============
Net income (loss) per common share              $      (0.47)      $      (0.65)
                                                ============       ============






























                 See Notes to Consolidated Financial Statements


                                       3
<PAGE>

                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                        CONSOLIDATED STATEMENTS OF INCOME





                                                        Six Months Ended
                                                   June 30,           June 30,
                                                     1998              1997
                                                ------------       ------------
Revenues:
     Healthcare ..............................  $    492,579       $    798,581
     Entertainment ...........................        10,000               -   
                                                ------------       ------------
                                                     502,579            798,581
Operating Costs:
     Healthcare ..............................        56,458            301,079 
     Entertainment ...........................         2,293               -   
Selling, general and administrative expenses .       894,654            862,179
Settlement Expense                                   267,236               -
                                                 ------------       ------------
                                                   1,220,641          1,163,258
     
Net income (loss) ............................  $   (718,062)          (364,677)
                                                ============       ============
Weighted average number of shares outstanding      1,000,273            407,199
                                                ============       ============
Net income (loss) per common share              $      (0.75)      $      (0.97)
                                                ============       ============






























                 See Notes to Consolidated Financial Statements


                                       4
<PAGE>


                             JUNIPER GROUP, INC.
                            AND SUBSIDIARY COMPANIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS


                                                        Six Months Ended
                                                    June 30,         June 30,
                                                     1998              1997
                                                 ------------      ------------
Operating Activities
Net income (loss) ............................   $   (718,062)     $   (364,677)
 Adjustments to reconcile net cash provided
  by operating activities:
 Amortization expense.........................           -                 -
 Depreciation expense ........................          5,955            20,479
 Settlement Expense                                   267,236              -
 Gain on disposition of assets ...............         (6,362)             - 
 Payment of officer's compensation with equity        209,724            28,093
 Payment of officer's deffered compensation salary       -               23,620
 Payment of various liabilities with equity ..        112,275            67,740
 Payment of directors compenations with equity         35,250            18,000
 Payment of employees compensation with equity                           32,500
Changes in assets and liabilities:
 Accounts receivable .........................        (87,026)           30,464
 Prepaid expenses and other current assets ...         (2,264)          (19,217)
 Other assets                                          (1,605)              158
 Due to/from officers ........................       (164,557)            4,650
 Due from affiliates .........................          5,309             2,567
Accounts payable and accrued expenses .......         (17,591)           92,006 
                                                 ------------         ---------
 Net cash provided from (used for)                   (361,718)          (63,617)
   operating activities ......................                         
                                                 ------------         ---------

Investing activities:
 Sale (purchase) of equipment ................        (5,250)              -   
                                                 ------------         ---------
Financing activities:
 Reduction in borrowings .....................      (187,800)           (48,477)
 Proceeds from borrowings ....................       450,000            125,000
 Payments to and on behalf of producers ......       (53,818)           (38,101)
 Proceeds from private placements ............       150,000             11,000 
                                                 -----------          ---------
 Net cash provided from (used for)
   financing activities ......................       358,382             49,422
                                                 -----------          ---------
 Net increase (decrease in cash) .............        (8,586)           (14,195)
 Cash at beginning of period .................        30,187             14,593
                                                 -----------          ---------
 Cash at end of period .......................   $    21,601          $     398 
                                                 ===========          =========

Supplemental cash flow information:
  Interest paid ..............................   $    14,196          $   4,763
                                                 -----------          ---------









                 See Notes to Consolidated Financial Statements

                                       5
<PAGE>

                              JUNIPER GROUP, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
                                   (Unaudited)

NOTE 1 - Basis of Presentation:

The interim consolidated financial statements included herein have been prepared
without  audit,  pursuant to the rules and  regulations  of the  Securities  and
Exchange  Commission  ("SEC").  Certain  information  and footnote  disclosures,
normally  included  in the  financial  statements  prepared in  accordance  with
generally  accepted  accounting  principles,  have  been  condensed  or  omitted
pursuant to SEC rules and regulations;  nevertheless,  management of the Company
believes  that the  disclosures  herein  are  adequate  to make the  information
presented not misleading. The consolidated financial statements and notes should
be read in conjunction with the audited  consolidated  financial  statements and
notes  thereto as of December  31, 1997  included in the  Company's  Form 10-KSB
filed with SEC.

In the  opinion  of  management,  all  adjustments  consisting  only  of  normal
recurring  adjustments  necessary to present fairly the  consolidated  financial
position  of the Company  with  respect to the  interim  consolidated  financial
statements have been made. The results of operations for the interim periods are
not necessarily indicative of the results to be expected for the full year.





































                                        6
<PAGE>
Item 2. MANAGEMENT'S  DISCUSSION  AND ANALYSIS OR PLAN OF OPERATION

The  following  discussion  and analysis of financial  condition  and results of
operations  should  be read  in  conjunction  with  the  Company's  consolidated
financial statements and notes thereto included elsewhere herein. The statements
disclosed  herein  include  forward-looking  statements  within  the  meaning of
Section  27A of the  Securities  Act of 1933,  as amended and Section 21E of the
Securities Exchange Act of 1934, as amended.  The Company's actual results could
differ  materially from those projected in the  forward-looking  statements as a
result of certain risks and  uncertainties,  including,  but not limited to, the
Company's  historical lack of  profitability,  the Company's need for additional
financing,  competition  in the managed  health care  industry,  and other risks
detailed  from time to time in the  Company's  filings with the  Securities  and
Exchange Commission.

OVERVIEW
- --------

Juniper  Group,  Inc.  (the  "Company")is  a Nevada  Corporation.  Its principal
businesses are composed of two segments,  healthcare and entertainment:  (i) the
healthcare  operations are conducted through two subsidiaries of Juniper Medical
Systems,  Inc. ("JMSI"),  which is a wholly owned subsidiary of the Company: (a)
PartnerCare,  Inc. ("PCI"), a managed care revenue enhancement company providing
various types of services such as: Physician Practice  Management,  Managed Care
Revenue  Enhancement,   Comprehensive   Pricing  Reviews,   MSOs  and  Liability
Assessment  Programs to newly evolving integrated hospital and physician markets
and (b) Juniper Healthcare  Containment  Systems,  Inc.  ("Containment"),  which
develops and provides full service healthcare  networks for insurance  companies
and managed  care  markets in the  Northeast  U.S.;  and (ii) the  entertainment
segment is conducted principally through Juniper Pictures, Inc. ("Pictures"),  a
wholly owned subsidiary of Juniper  Entertainment,  Inc. ("JEI"), a wholly owned
subsidiary of the Company,  which engages in the  acquisition,  exploitation and
distribution of rights to films to the various media (i.e., home video,  pay-per
view, pay television,  cable  television,  networks and  independent  syndicated
television  stations)  in the domestic and foreign  marketplace.  The  Company's
operations  are based at 111 Great Neck Road,  Suite 604,  Great Neck,  New York
11021.

RESULTS OF OPERATIONS
- ---------------------

Three  Months  Ended June 30,  1998 vs Three  Months  Ended  June 30,  1997
- ---------------------------------------------------------------------------
Revenue  related to the Healthcare  segment  decreased to $284,000 in the second
quarter of 1998 from $302,000 in the second  quarter of 1997,  representing a 6%
decrease.  The  decrease  in  revenue  during  the  second  quarter  of 1998 was
predominately  attributed  to  Containment,  which had revenue of  approximately
$53,000 in the second quarter of 1998, compared to approximately $184,000 in the
second quarter of 1997, a 71% decrease.  This is a result of changes  instituted
in December 1997, whereby  Containment  discontinued a joint venture arrangement
and its  arrangement  with  the  Guardian  Insurance  Company.  The loss of this
business has been temporarily replaced with a settlement agreement involving the
joint  venture,  which  will  generate  revenue  with no  corresponding  expense
throughout 1998.  PCI's revenue  increased to $231,000 in 1998, from $119,000 in
1997.  This was the result of PCI's  success in  marketing  its new Managed Care
Revenue Enhancement Program, resulting in a growing number of hospital clients.

The entertainment  segment recognized revenue of 10,000 in the second quarter of
1998,  and none in the second  quarter of 1997.  Certain of the Company's  films
that  generated  revenue when the contracts were signed are still under license,
and are  currently  being  aired by the  licensees.  The  Company  is  currently
utilizing its resources to build the healthcare segment of its business, and has
not devoted  resources  toward the  promotion and  solicitation  of the films in
1997. However, the Company has begun looking for outside salesmen to help market
and marchandise the films that are not currently under license.

Healthcare  operating  costs  decreased to $35,000 in the second quarter of 1998
from $124,000 in the second quarter of 1997, a 72% decrease.  As a percentage of
revenue,  operating costs of the healthcare  operations  decreased to 12% in the
second  quarter of 1998 from 41% in the second  quarter of 1997. The decrease is
due to the fact that operating costs for  Containment  were lower because of the
new Settlement Agreement.
 


                                      7

<PAGE>
Selling, general and administrative expenses increased to $474,000 in the second
quarter of 1998 from $444,000 in the second quarter of 1997, a 7% increase. This
change is primarily due to increases in consulting  fees of $23,000,  Director's
Compensation  of $17,000,  insurance of $13,000,  Interest of $13,000 and travel
expenses of  $12,000,  offset by a reduction  of salaries  and related  taxes of
$56,000.  Most of the  decrease  was  related to the  management  changes in PCI
during  1997  and  the  corresponding  redirection  of  time  and  resources  of
management  initiatives to re-engineer  and diversify  product lines through the
development of the new information systems.

 
RESULTS OF OPERATIONS
- ---------------------

Six  Months  Ended  June  30,  1998  vs Six  Months  Ended  June  30,  1997
- ---------------------------------------------------------------------------
Revenue  related to the  Healthcare  segment  decreased to $493,000  through the
second  quarter  of 1998 from  $799,000  through  the  second  quarter  of 1997,
representing a 38% decrease.  The decrease in revenue through the second quarter
of 1998 was  predominately  attributed  to  Containment,  which had  revenue  of
approximately   $162,000  through  the  second  quarter  of  1998,  compared  to
approximately $468,000 in the second quarter of 1997, a 65% decrease.  This is a
result of changes instituted in December 1997, whereby Containment  discontinued
a joint venture  arrangement  and its  arrangement  with the Guardian  Insurance
Company.  The  loss  of this  business  has  been  temporarily  replaced  with a
settlement  agreement  involving the joint venture,  which will generate revenue
with no  corresponding  expense  throughout  1998.  PCI's  revenue  in 1998  was
$331,000,  unchanged from 1997. This was the result of PCI's change in direction
from a DRG audit company to a Managed Care Revenue Enhancement company.

The  entertainment  segment  recognized  $10,000 in revenue  through  the second
quarter of 1998,  and none  through the second  quarter of 1997.  Certain of the
Company's films that generated  revenue when the contracts were signed are still
under license,  and are currently  being aired by the licensees.  The Company is
currently  utilizing  its  resources  to build  the  healthcare  segment  of its
business, and has not devoted resources toward the promotion and solicitation of
the films in 1997.  However,  the Company has begun looking for outside salesmen
to help market and marchandise the films that are not currently under license.

Healthcare  operating  costs  decreased to $56,000 through the second quarter of
1998  from  $301,000  in the  second  quarter  of  1997,  a 81%  decrease.  As a
percentage of revenue, operating costs of the healthcare operations decreased to
11%  through the second  quarter of 1998 from 38% through the second  quarter of
1997. The decrease is due to the fact that operating costs for Containment  were
lower because of the new Settlement Agreement.
 
Selling,  general and administrative  expenses increased to $895,000 through the
second  quarter of 1998 from $862,000  through the second  quarter of 1997, a 4%
increase.  This change is  primarily  due to  increases  in bad debt  expense of
$69,000(due  to  a  more  conservative  evaluation  of  the  Company's  accounts
receivable),  Director's  Compensation expense of $16,000 and consulting fees of
$19,000, offset by a reduction of salaries and related taxes of $68,000. Most of
this decrease was related to the  management  changes in PCI during 1997 and the
corresponding  redirection  of time and resources of management  initiatives  to
re-engineer  and  diversify  product lines  through the  development  of the new
information systems.

LIQUIDITY AND CAPITAL RESOURCES
- -------------------------------
Working  capital  deficiency at June 30, 1998 was $885,000,  compared to working
capital deficiency of $765,000 at December 31, 1997. The ratio of current assets
to current  liabilities  was .45:1 at June 30,  1998 and .42.1 at  December  31,
1997.  Cash  flow used in  operations  during  the  second  quarter  of 1998 was
$362,000,  compared to cash flow used in operations during the second quarter of
1997, of $64,000.

     Accounts receivable - trade increased to $451,000 from $363,000 at December
     31, 1997.

     Accounts payable decreased to $818,000 from $835,000 at December 31, 1997.

     Although the Company plans to continue to expand its healthcare business to
the extent that  resources  are  available,  the  Company  has no firm  material
commitments  for capital  expenditures in other areas of its business and has no
plans to acquire additional films.

     The Company believes that it may not have sufficient  liquidity to meet its
operating  cash  requirements  for the current  level of  operations  during the
remainder of 1998. The Company will require additional  financing.  There can be
no  assurance  that  financing  will be  available,  or if  available, on  terms
acceptable to the Company.  If the Company is unable to fund its operating  cash
flow needs, the Company may be required to substantially curtail operations.



                                       8

<PAGE>


     The Company currently does not have any bank lines of credit.

     At  the  Company's  annual  meeting,  management  eliminated  shareholders'
pre-emptive rights, which previously existed under New York law. Notwithstanding
these rights,  the Company has on a number of occasions  issued  shares  without
affording  shareholders  the  opportunity  to  exercise  pre-emptive  rights and
without  procuring waivers of such rights. No shareholder has alleged any damage
resulting  to him as a  result  of the sale of  shares  by the  Company  without
offering  pre-emptive  rights. The amount of damages incurred by shareholders by
reason of the failure of the Company to offer pre-emptive rights, if any, is not
ascertainable  with any degree of accuracy.  Management  believes that if claims
were asserted alleging damages, the Company may have valid defenses.

























































                                       9

<PAGE>

PART II:   OTHER INFORMATION

Item 1. Legal Proceedings
        -----------------

     On  April  17,  1998,  Juniper  Group,  Inc.,  a  Nevada  corporation  (the
"Registrant"),  entered into a Stipulation of Settlement (the  "Settlement")  to
settle a lawsuit (the "Action") by Ordinary Guy, Inc. and Crow Productions, Inc.
(the  "Plaintiffs")  against the Registrant,  Juniper  Pictures,  Inc.,  Juniper
Entertainment,  Inc.,  and Vlado P.  Hreljanovic  that was pending in the United
States  District Court for the Eastern  District of New York,  Case No.: 96 Civ.
2542 (the "Lawsuit").  Under the terms of the Settlement,  Registrant  agreed to
pay a total of $310,000 to the plaintiffs as follows:  $50,000 in cash,  payable
on or before April 20, 1998; $10,000 in cash, payable on or before May 20, 1998;
and $250,000 by a promissory note, secured and funded by 93,320 shares of the
Registrant's  common  stock,  $.001 par value,  to be held in escrow  jointly by
counsel for the parties, providing for three equal payments of $83,333.33 due on
April 21, 1999, April 21, 2000 and April 21, 2001 (The "Payment Dates").

     Payments   under  the  Note  shall  be  funded  by  93,320  shares  of  the
Registrant's common stock, $001 par value (the "Juniper Shares"),  to be held in
escrow jointly by counsel for the parties.  On each successive Payment Date, one
third of the Juniper  Shares shall be released from the escrow and sold in order
to make the  payment  then  due.  Any  proceeds  from  such  sale in  excess  of
$83,333.33 shall be applied to the next payment due under the Note. In the event
that the Note is  satisfied  in full  prior to April  21,  2001,  the  remaining
Juniper shares in escrow shall be released to and retained by Plaintiffs. In the
event that the proceeds from such sale are  insufficient  to make a payment when
due,  registrant  shall be  responsible  for  paying any  deficiency.  Upon full
satisfaction  of the payment  provisions of the  Settlement,  the Action will be
dismissed  with  prejudice  and  each  of the  defendants  will be  released  by
Plaintiffs from any claims or liabilities  that were or could have been asserted
in the Action.

Item  2.  Changes  in  Securities
          -----------------------

(a)  N/A

(b)  N/A

(c) Common Stock, $0.001 par value, sold through the second quarter of 1998
were as follows:

<TABLE>
<CAPTION>

       Date              Purchaser          Amount (#)         Amt. Paid ($)       Description         Exemption
- -------------------- ------------------ ------------------- ------------------  ------------------- -----------------
<S>  <C>               <C>                 <C>                  <C>                    <C>              <C>
     6/30/98           Officers            139,818              209,724                (1)               4(2)
     6/30/98           Vendors             205,244              112,275                (2)               4(2)
     6/30/98            Reg S              148,721              240,000                (3)              Reg. S
     6/30/98           Directors            47,000               35,250                (4)               4(2)
</TABLE>
_______________________

(1)  The  President  and CEO of the  Company  accepted  common  stock in lieu of
     accrued salary.

(2)  Vendors accepted common stock in lieu of unpaid fees.

(3)  A non-U.S. consultant  accepted common stock in lieu of  consulting  fees
     relating to public relations services provided to the Company.

(4)  The Board of Directors accepted common stock in lieu of cash compensation.


                                       10
<PAGE>

Item 3.  Defaults  Upon Senior  Securities
         ---------------------------------

Preferred  Stockholders are entitled to receive out of assets legally  available
for  payment  a  dividend  at a rate of 12% per  annum  of the  Preferred  Stock
liquidation preference of $2.00 (or $.24 per annum) per share, payable quarterly
on March 1, June 1,  September 1 and  December 1, in cash or in shares of Common
Stock having an equivalent fair market value.  Unpaid dividends on the Company's
Preferred Stock cumulate. The quarterly payments due on September 1 and December
1, 1992,  and all payments due in 1993,  in 1994,  in 1995, in 1996, in 1997 and
the  payments  due on March 1, and June 1,  1998  have not yet been paid and are
accumulating.  These dividends have not been declared  because earned surplus is
not available to pay a cash dividend.  Accordingly,  dividends  will  accumulate
until such time as earned surplus is available to pay a cash dividend or until a
post  effective  amendment to the Company's  registration  statement  covering a
certain  number of common  shares  reserved for the payment of  Preferred  Stock
dividends is filed and declared  effective,  or if such number of common  shares
are  insufficient  to pay cumulative  dividends,  then until  additional  common
shares are  registered  with the Securities and Exchange  Commission  (SEC).  No
dividends  shall be declared or paid on the Common  Stock (other than a dividend
payable  solely  in  shares  of  Common  Stock)  and no  Common  Stock  shall be
purchased,  redeemed or acquired by the Company unless full cumulative dividends
on the Preferred  Stock have been paid or declared,  or cash or shares of Common
Stock have been set apart which is sufficient  to pay all  dividends  accrued on
the Preferred Stock for all past and then current dividend periods.

     As stated above,  pursuant to the terms of the Preferred Stock, the Company
has the option of making quarterly dividend payments in cash or shares of Common
Stock. The Company does not intend to make any Preferred Stock dividends in cash
in the foreseeable future.  Prospectively,  subject to the Company's  Prospectus
being current,  and a sufficient  number of common shares being  registered with
the SEC, the Company anticipates making quarterly dividend payments in shares of
Common Stock for the  foreseeable  future  including the payments which have not
yet been made.  The total cash value of the  arrearage  of unpaid  dividends  is
$340,000.

Item 6.  Exhibits and Reports on Form 8-K
         --------------------------------
 (a) Exhibits

Exhibit                  Description 

 3.1  Certificate of Incorporation of the Registrant, as amended (1)

 3.2  Amendment to the Certificate of Incorporation of the Registrant, filed
      March 7, 1998 (2)

 3.3  Certificate of Incorporation of Juniper Group, Inc., a Nevada
      corporation.(3)

 3.4  By-Laws of the Registrant (1)

 3.5  Amendment to the By-Laws of the Registrant approved by the shareholders
      of the Registrant on February 12, 1998 (3)

 3.6  By-Laws of Juniper Group, Inc., a Nevada corporation (3)

27.1  Financial Data Schedule
- ----  -----------------------

     (1) Incorporated by reference to the Company's Annual Report on Form 10-KSB
     for the fiscal year ended December 31, 1995

     (2) Incorporated by reference to the Company's Annual Report on Form 10-KSB
     for the fiscal year ended December 31, 1997

     (3) Incorporated by reference to the Company's Proxy  Statement for its
     Annual Meeting held in February 1998

(b)      Reports on Form 8-K.

     (1) The Company filed a Form 8-K on April 1, 1998, relating to the sale of
         equity pursuant to Regulation S.

     (2) The  Company  filed  a Form  8-K on  April  28,  1998, relating to the
         the Stipulation of Settlement, Ordinary Guy, Inc. and Crow Productions,
         Inc. against the Registrant.

     (3) The Company filed a Form 8-K on May 18, 1998, relating to a 
         one-for-fifty reverse stock split, effective at the close of business
         on May 18, 1998.
            


                                       11

<PAGE>







                                   SIGNATURES



     In accordance  with the  requirements  of the Exchange Act, the  Registrant
caused this report to be signed by the undersigned, thereunto duly authorized.



                                        JUNIPER GROUP, INC.



Date:           , 1998



                                        By:/s/ Vlado P. Hreljanovic
                                           ------------------------
                                            Vlado P. Hreljanovic
                                            Chairman of the Board, President,
                                            Chief Executive Officer and Acting
                                            Chief Financial Officer
 







































                                       12
<PAGE>


                                EXHIBIT INDEX


Exhibit                            Description


27.1  Financial Data Schedule




<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME FOUND ON PAGES
3 & 4 OF THE COMPANY'S FORM 10-QSB FOR THE THREE MONTHS ENDED June 30, 1998.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-mos
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   JUN-30-1998
<CASH>                                         21,601
<SECURITIES>                                   0
<RECEIVABLES>                                  450,506
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               721,625
<PP&E>                                         136,003
<DEPRECIATION>                                 69,271
<TOTAL-ASSETS>                                 3,744,707
<CURRENT-LIABILITIES>                          1,606,726
<BONDS>                                        0
                          0
                                    23,590
<COMMON>                                       1,301
<OTHER-SE>                                     2,050,594
<TOTAL-LIABILITY-AND-EQUITY>                   3,744,707
<SALES>                                        0
<TOTAL-REVENUES>                               502,579
<CGS>                                          0
<TOTAL-COSTS>                                  1,220,641
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (718,062)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (718,062)
<EPS-PRIMARY>                                  (.75)                                
<EPS-DILUTED>                                  (.75)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission